Diosmetin induces human osteoblastic differentiation through the protein kinase C/p38 and extracellular signal-regulated kinase 1/2 pathway

Journal of Bone and Mineral Research

Volumn 23, Issue 6, 2008, Pages 949-960

  Hsu, Ya Ling ^a   Kuo, Po Lin ^a  

^a CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

Differentiation; Diosmetin; Mitogen activated protein kinase; Osteoblast; Protein kinase C

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; DIOSMETIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCALCIN; OSTEOPONTIN; PROTEIN KINASE C; PROTEIN KINASE C DELTA; RAC1 PROTEIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL SURVIVAL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MINERALIZATION; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; STROMA CELL;

ANIMALS; BONE MARROW; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; ENZYME ACTIVATION; FLAVONOIDS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; OSTEOBLASTS; PHOSPHORYLATION; PROTEIN KINASE C-DELTA; RAC1 GTP-BINDING PROTEIN; STROMAL CELLS;

EID: 44449100174     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.080219     Document Type: Article

References (51)

1. Manolagas SC, Jilka RL 1995 Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305-311.
2. Ducy P, Schinke T, Karsenty G 2000 The osteoblast: A sophisticated fibroblast under central surveillance. Science 289:1501-1504.
3. Teitelbaum SL 2000 Osteoclasts, integrins, and osteoporosis. J Bone Miner Metab 18:344-349.
4. Wang X, Goh CH, Li B 2007 p38 mitogen-activated protein kinase regulates osteoblast differentiation through osterix. Endocrinology 148:1629-1637.
5. Rodan GA, Martin TJ 2000 Therapeutic approaches to bone diseases. Science 289:1508-1514.
6. Berg C, Neumeyer K, Kirkpatrick P 2003 Teriparatide. Nat Rev Drug Discov 2:257-258.
7. Lane NE, Kelman A 2003 A review of anabolic therapies for osteoporosis. Arthritis Res Ther 5:214-222.
8. Raman M, Chen W, Cobb MH 2007 Differential regulation and properties of MAPKs. Oncogene 26:3100-3112.
9. Molina JR, Adjei AA 2006 The Ras/Raf/MAPK pathway. J Thorac Oncol 1:7-9.
10. Li CF, Hughes-Fulford M 2006 Fibroblast growth factor-2 is an immediate-early gene induced by mechanical stress in osteogenic cells. J Bone Miner Res 21:946-955.
11. Miguel SM, Namdar-Attar M, Noh T, Frenkel B, Bab I 2005 ERK1/2-activated de novo Mapkapk2 synthesis is essential for osteogenic growth peptide mitogenic signaling in osteoblastic cells. J Biol Chem 280:37495-37502.
12. Ghosh-Choudhury N, Mandal CC, Choudhury GG 2007 Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation. J Biol Chem 282:4983-4993.
13. Ge C, Xiao G, Jiang D, Franceschi RT 2007 Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. J Cell Biol 176:709-718.
14. Kanno T, Takahashi T, Tsujisawa T, Ariyoshi W, Nishihara T 2007 Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts. J Cell Biochem 101:1266-1277.
15. Fan D, Chen Z, Wang D, Guo Z, Qiang Q, Shang Y 2007 Osterix is a key target for mechanical signals in human thoracic ligament flavum cells. J Cell Physiol 211:577-584.
16. Hsu YL, Chang JK, Tsai CH, Chien TT, Kuo PL 2007 Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated protein kinase pathway. Biochem Pharmacol 73:504-514.
17. Migliaccio S, Bernardini S, Wetsel WC, Korach KS, Faraggiana T, Teti A 1998 Protein kinase C modulates estrogen receptors in differentiated osteoblastic cells in vitro. Steroids 63:352-354.
18. Griner EM, Kazanietz MG 2007 Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 7:281-294.
19. Kim BG, Kim HJ, Park HJ, Kim YJ, Yoon WJ, Lee SJ, Ryoo HM, Cho JY 2006 Runx2 phosphorylation induced by fibroblast growth factor-2/protein kinase C pathways. Proteomics 6:1166-1174.
20. Kim HJ, Kim JH, Bae SC, Choi JY, Kim HJ, Ryoo HM 2003 The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J Biol Chem 278:319-326.
21. Yang D, Guo J, Divieti P, Bringhurst FR 2006 Parathyroid hormone activates PKC-delta and regulates osteoblastic differentiation via a PLC-independent pathway. Bone 38:485-496.
22. Hall KJ, Jones ML, Poole AW 2007 Coincident regulation of PKCdelta in human platelets by phosphorylation of Tyr(311) and Tyr(565) and phospholipase C signalling. Biochem J 406:501-509.
23. Kaul S, Anantharam V, Yang Y, Choi CJ, Kanthasamy A, Kanthasamy AG 2005 Tyrosine phosphorylation regulates the proteolytic activation of protein kinase Cdelta in dopaminergic neuronal cells. J Biol Chem 280:28721-28730.
24. Choi EM 2007 Apigenin increases osteoblastic differentiation and inhibits tumor necrosis factor-alpha-induced production of interleukin-6 and nitric oxide in osteoblastic MC3T3-E1 cells. Pharmazie 62:216-220.
25. Morris C, Thorpe J, Ambrosio L, Santin M 2006 The soybean isoflavone genistein induces differentiation of MG63 human osteosarcoma osteoblasts. J Nutr 136:1166-1170.
26. Doostdar H, Burke MD, Mayer RT 2000 Bioflavonoids: Selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology 144:31-38.
27. Bae EA, Han MJ, Kim DH 1999 In vitro anti-Helicobacter pylori activity of some flavonoids and their metabolites. Planta Med 65:442-443.
28. Ciolino HP, Wang TT, Yeh GC 1998 Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity. Cancer Res 58:2754-2760.
29. Reinholz GG, Getz B, Pederson L, Sanders ES, Subramaniam M, Ingle JN, Speisberg TC 2000 Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res 60:6001-6007.
30. Shin CS, Jeon MJ, Yang JY, Her SJ, Kim D, Kim SW, Kim SY 2006 CCAAT/enhancer-binding protein delta activates the Runx2-mediated transcription of mouse osteocalcin II promoter. J Mol Endocrinol 36:531-546.
31. Jackson AL, Burchard J, Leake D, Reynolds A, Schelter J, Guo J, Johnson JM, Lim L, Karpilow J, Nichols K, Marshall W, Khvorova A, Linsley PS 2006 Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing. RNA 12:1197-1205.
32. Fedorov Y, Anderson EM, Birmingham A, Reynolds A, Karpilow J, Robinson K, Leake D, Marshall WS, Khvorova A 2006 Off-target effects by siRNA can induce toxic phenotype. RNA 12:1188-1196.
33. Lee JS, Thomas DM, Gutierrez G, Carty SA, Yanagawa S, Hinds PW 2006 HES1 cooperates with pRb to activate RUNX2-dependent transcription. J Bone Miner Res 21:921-933.
34. Deyhim F, Garica K, Lopez E, Gonzalez J, Ino S, Garcia M, Patil BS 2006 Citrus juice modulates bone strength in male senescent rat model of osteoporosis. Nutrition 22:559-563.
35. Prouillet C, Mazière JC, Mazière C, Wattel A, Brazier M, Kamel S 2004 Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem Pharmacol 67:1307-1313.
36. Celil AB, Campbell PG 2005 BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J Biol Chem 280:31353-31359.
37. Kuo PL, Hsu YL, Chang CH, Chang JK 2005 Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells. J Pharmacol Exp Ther 314:1290-1299.
38. Chae HJ, Jeong BJ, Ha MS, Lee JK, Byun JO, Jung WY, Yun YG, Lee DG, Oh SH, Chae SW, Kwak YG, Kim HH, Lee ZH, Kim HR 2002 ERK MAP Kinase is required in 1,25(OH)2D3-induced differentiation in human osteoblasts. Immunopharmacol Immunotoxicol 24:31-41.
39. Hu Y, Chan E, Wang SX, Li B 2003 Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation. Endocrinology 144:2068-2074.
40. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T 1997 Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
41. Phillips JE, Gersbach CA, Wojtowicz AM, García AJ 2006 Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation. J Cell Sci 119:581-591.
42. Franceschi RT, Xiao G 2003 Regulation of the osteoblast-specific transcription factor, Runx2: Responsiveness to multiple signal transduction pathways. J Cell Biochem 88:446-454.
43. Balasubramanian S, Zhu L, Eckert RL 2006 Apigenin inhibition of involucrin gene expression is associated with a specific reduction in phosphorylation of protein kinase Cdelta Tyr311. J Biol Chem 281:36162-36172.
44. Czifra G, Tóth IB, Marincsák R, Juhász I, Kovács I, Acs P, Kovács L, Blumberg PM, Bíró T 2006 Insulin-like growth factor-I-coupled mitogenic signaling in primary cultured human skeletal muscle cells and in C2C12 myoblasts. A central role of protein kinase Cdelta. Cell Signal 18:1461-1472.
45. Zhao KW, Li X, Zhao Q, Huang Y, Li D, Peng ZG, Shen WZ, Zhao J, Zhou Q, Chen Z, Sims PJ, Wiedmer T, Chen GQ 2004 Protein kinase Cdelta mediates retinoic acid and phorbol myristate acetate-induced phospholipid scramblase 1 gene expression: Its role in leukemic cell differentiation. Blood 104:3731-3738.
46. Tu X, Joeng KS, Nakayama KI, Nakayama K, Rajagopal J, Carroll TJ, McMahon AP, Long F 2007 Noncanonical Wnt signaling through G protein-linked PKCdelta activation promotes bone formation. Dev Cell 12:113-127.
47. Slupsky JR, Kamiguti AS, Harris RJ, Cawley JC, Zuzel M 2007 Central role of protein kinase Cepsilon in constitutive activation of ERK1/2 and Rac1 in the malignant cells of hairy cell leukemia. Am J Pathol 170:745-754.
48. Laboureau J, Dubertret L, Lebreton-De Coster C, Coulomb B 2004 ERK activation by mechanical strain is regulated by the small G proteins rac-1 and rhoA. Exp Dermatol 13:70-77.
49. Shin I, Kim S, Song H, Kim HR, Moon A 2005 H-Ras-specific activation of Rac-MKK3/6-p38 pathway: Its critical role in invasion and migration of breast epithelial cells. J Biol Chem 280:14675-14683.
50. Woolfolk EA, Eguchi S, Ohtsu H, Nakashima H, Ueno H, Gerthoffer WT, Motley ED 2005 Angiotensin II-induced activation of p21-activated kinase 1 requires Ca2+ and protein kinase C{delta} in vascular smooth muscle cells. Am J Physiol Cell Physiol 289:C1286-C1294.
51. Schuringa JJ, Dekker LV, Vellenga E, Kruijer W 2001 Sequential activation of Rac-1, SEK-1/MKK-4, and protein kinase Cdelta isrequired for interleukin-6-induced STAT3 Ser-727 phosphorylation and transactivation. J Biol Chem 276:27709-27715.